304 related articles for article (PubMed ID: 24944075)
1. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Handley AP; Williams M
J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
[TBL] [Abstract][Full Text] [Related]
2. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
Azizi M; Khani S; Kamali M; Elyasi F
Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
[TBL] [Abstract][Full Text] [Related]
6. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
7. Use of antidepressants for management of hot flashes.
Carroll DG; Kelley KW
Pharmacotherapy; 2009 Nov; 29(11):1357-74. PubMed ID: 19857151
[TBL] [Abstract][Full Text] [Related]
8. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Strawn JR; Mills JA; Croarkin PE
J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
[No Abstract] [Full Text] [Related]
9. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause.
Fugate SE; Church CO
Ann Pharmacother; 2004 Sep; 38(9):1482-99. PubMed ID: 15292498
[TBL] [Abstract][Full Text] [Related]
10. Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms.
Witten T; Staszkiewicz J; Gold L; Granier MA; Klapper RJ; Lavespere G; Dorius B; Allampalli V; Ahmadzadeh S; Shekoohi S; Kaye AD; Varrassi G
Cureus; 2024 Jan; 16(1):e52467. PubMed ID: 38371081
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
Speroff L; Gass M; Constantine G; Olivier S;
Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
[TBL] [Abstract][Full Text] [Related]
12. Managing vasomotor symptoms in women after cancer.
Pinkerton JV; Santen RJ
Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
[TBL] [Abstract][Full Text] [Related]
14. Clinical Inquiries: Does exercise relieve vasomotor menopausal symptoms?
Lyon C; Mullen R; Deffenbacher B; Reed A; Nashelsky J
J Fam Pract; 2018 Mar; 67(3):175-176. PubMed ID: 29509823
[TBL] [Abstract][Full Text] [Related]
15. Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
Alexander IM; Moore A
J Am Acad Nurse Pract; 2007 Mar; 19(3):152-63. PubMed ID: 17341283
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of nonhormonal drugs on menopausal hot flashes.
Li L; Xu L; Wu J; Dong L; Zhao S; Zheng Q
Eur J Clin Pharmacol; 2016 Sep; 72(9):1051-8. PubMed ID: 27450233
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Albertazzi P
J Br Menopause Soc; 2006 Mar; 12(1):7-11. PubMed ID: 16513016
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
19. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
Kelsberg G; Maragh L; Safranek S
J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
Menown SJ; Tello JA
Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
